HHS and Pfizer Reach Agreement to Increase Patient Access to Paxlovid

U.S. Department of Health and Human Services. (2023). HHS and Pfizer Reach Agreement to Increase Patient Access to Paxlovid.
This press release explains how HHS and Pfizer reached an agreement that extends patient access to Paxlovid, maximizes taxpayer investment, and begins Paxlovid’s transition to the commercial market in November 2023.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.